Inventor · disambiguated record
Thomas Trieselmann
Also filed as: TRIESELMANN THOMAS
20 granted patents·11 pending applications·90 citations·filing 2003–2023
93Inventor score
Files withBOEHRINGER INGELHEIM INT11CENTREXION THERAPEUTICS CORP5EBEL HEINER5TRIESELMANN THOMAS5BOEHRINGER INGELHEIM PHARMA2
Top patents by PatentIndex Score
31 records- 0192US7214698B2Beta-agonists, processes for preparing them and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2006·Granted May 8, 2007·11 cites·6 claims
- 0291US11046706B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2018·Granted Jun 29, 2021·3 cites·26 claims
- 0391US10196402B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2017·Granted Feb 5, 2019·7 cites·31 claims
- 0491US9067951B2Process and intermediates for the production of CCR2 antagonistsEBEL HEINER·Filed 2014·Granted Jun 30, 2015·20 cites·9 claims
- 0589US11731981B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2021·Granted Aug 22, 2023·1 cites·20 claims
- 0689US9670222B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2014·Granted Jun 6, 2017·9 cites·23 claims
- 0788US8765949B2CCR2 receptor antagonists and uses thereofEBEL HEINER·Filed 2010·Granted Jul 1, 2014·9 cites·39 claims
- 0888US7977334B2Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2008·Granted Jul 12, 2011·14 cites·18 claims
- 0986US12209094B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2023·Granted Jan 28, 2025·0 cites·20 claims
- 1086US8835440B2Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPDEBEL HEINER·Filed 2013·Granted Sep 16, 2014·9 cites·15 claims
- 1180US11319310B2Heterocyclyl-substituted oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted May 3, 2022·1 cites·16 claims
- 1280US11254688B2Benzyl-, (pyridin-3-yl)methyl -or (pyridin-4-yl)-methyl-substituted oxadiazolopyridine derivatives as ghrelin O-acyl transferase (GOAT) inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Feb 22, 2022·1 cites·18 claims
- 1379US11136337B2Pyrazole- and indazole-substituted oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Oct 5, 2021·1 cites·15 claims
- 1475US10308667B2Oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Jun 4, 2019·1 cites·12 claims
- 1575US9994591B2Oxadiazolopyridine derivates for use as ghrelin O-acyl transferase (GOAT) inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Jun 12, 2018·1 cites·38 claims
- 1670US9029544B2Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparationWAGNER HOLGER·Filed 2011·Granted May 12, 2015·2 cites·15 claims
- 1767USRE49446EOxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Mar 7, 2023·0 cites·37 claims
- 1864US2012053164A1Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copdEBEL HEINER·Filed 2009·Application pending·0 cites
- 1949US2005245526A1Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 2049US2008103138A1Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositionsTRIESELMANN THOMAS·Filed 2007·Application pending·0 cites
- 2148US2004127733A1New beta-agonists, processes for preparing them and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Application pending·0 cites
- 2245US11583532B2Triazolopyrimidine derivatives for use as ghrelin o-acyl transferase (GOAT) inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Feb 21, 2023·0 cites·23 claims
- 2345US7754756B2Indol-containing beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2006·Granted Jul 13, 2010·0 cites·16 claims
- 2445US2007112033A1Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositionsTRIESELMANN THOMAS·Filed 2006·Application pending·0 cites
- 2545US2006094764A1Cyanothiophenes, their preparation and their use in pharmaceutical compositionsBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 2641US2008300290A1Novel Beta-Agonists, Process for Their Preparation and Their Use as MedicamentsWALTER RAINER·Filed 2006·Application pending·0 cites
- 2739US2013053404A1Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparationWAGNER HOLGER·Filed 2012·Application pending·0 cites
- 2838US2009221589A1Use of aminoalcohol derivatives for the treatment of overactive bladderTRIESELMANN THOMAS·Filed 2006·Application pending·0 cites
- 2937US2013143905A1Novel antagonists for ccr2 and uses thereofEBEL HEINER·Filed 2010·Application pending·0 cites
- 3037US2008269281A1Novel Beta-Agonists, Method for Producing Them and Their Use as DrugsTRIESELMANN THOMAS·Filed 2006·Application pending·0 cites
- 3135US9150583B2Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparationTRIESELMANN THOMAS·Filed 2012·Granted Oct 6, 2015·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Thomas Trieselmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →